Search results
405 Results for 'Synthetic Biology'
- Technologies (39)
- Collaborations (2)
- Team (0)
- News (283)
- Pages (0)
- Multimedia (81)
- Publications (0)
- Jobs (0)
- Events (0)
Technologies 39
-
Dispersible Gas Carriers: Enhancing Efficiency in Biomanufacturing
FluxBio is commercializing its dispersible gas carrier technology to enhance gas transfer in numerous biomanufacturing processes, increasing production at lower costs and with smaller environmental footprints. -
PFASense: Fast, In-Field Testing for Forever Chemicals
PFASense is a next-generation diagnostic tool designed to detect toxic ‘forever chemicals’ directly at the source. By combining engineered protein sensors with a portable electrochemical device, it enables real-time, low-cost monitoring of water supplies—providing actionable insights to protect health and guide remediation. -
GeneSkin: A Novel mRNA Therapy for Skin and Hair Rejuvenation
GeneSkin is developing novel mRNA therapies to rejuvenate skin and hair by targeting basal stem cells. Using advanced microneedle delivery, our non-invasive treatments aim to reduce scarring, reverse aging, and promote hair growth, offering transformative solutions for millions worldwide. -
GC Therapeutics: Changing the Future of Cell Therapies
GC Therapeutics (GCTx) is applying their stem cell-engineering TFome platform to overcome barriers in the development and manufacturing of cell therapies to improve patient access across a broad range of disease areas. -
Instrument-Free Molecular Diagnostics
A synthetic biology-based molecular diagnostics platform that enables the creation of low-cost, highly accurate tests for non-clinical settings. -
AminoX: Making Better Protein Drugs, Quicker and Cheaper
AminoX enables protein drugs to only become active in the tumor microenvironment and not elsewhere in the body to avoid immune-related adverse effects in the body. By designing and building non-standard amino acids into strategic positions of protein drugs, AminoX provides tumor-specific, and longer-lasting target inhibition.
Collaborations 2
-
Nucleic Acid Delivery Consortium
An academic-industry consortium focused on the challenge of delivering nucleic acid-based therapies to specific target organs, tissues, and cells. -
Brigham-Wyss DxA
The Wyss DxA's clinical partners from Brigham and Women’s Hospital identify the most pressing unmet diagnostic needs, provide access to high-quality patient samples for our Biomarker Discovery Laboratory (BDL) and Brigham-Wyss DxA collaborators, and provide invaluable feedback and guidance on the engineering and validation of cost-effective, sensitive, and specific diagnostic tests.
News 283
Multimedia 81
-
Video/AnimationInside the Wyss Institute at Harvard | Materials Saving the FutureFrom developing plastics that actually break down to adhesive gels for surgery, the Wyss Institute’s materials scientists are working to save the future. Four Wyss researchers, Principal Scientist in Sustainable Materials Emily Stoler, Ph.D., Senior Scientist Peter Nguyen, Ph.D., Wyss Lumineer Benjamin Freedman, Ph.D., and Postdoctoral Fellow Namrata Ramani, Ph.D., speak with host Ashley Christine... -
Video/AnimationCure ALD – Behind the Research | Alex LeNail – Safer Gene TherapyLearn about Wyss Postdoctoral Fellow Alex LeNail‘s background and how he plans to develop a safer gene therapy for ALD (adrenoleukodystrophy) patients. If successful, this could go to clinical trials and give families hope for a cure. This video series tells the story of the scientists behind the breakthroughs, and why community-driven fundraising is the... -
Audio/PodcastJames Collins: Doing Good Science with an Underdog Spirit – The Pulse PodcastJames J. Collins is a founding Core Faculty member at the Wyss Institute and the Termeer Professor of Medical Engineering & Science and Professor of Biological Engineering at MIT. Jim serves as a director at the MIT Jameel Clinic, a member of the Harvard-MIT Health Sciences & Technology Faculty, and a member of the Broad... -
Video/AnimationGeorge Church on Widespread Genomic Sequencing, Xenotransplantation, and Shepherding ChangeIn this interview, GenomeWeb speaks to Core Faculty member George Church, Ph.D., who is also a professor at Harvard Medical School and the Harvard-MIT Program in Health Sciences and Technology. A thinker, inventor, and collaborator extraordinaire, Church’s technologies and personality catalyzed the Human Genome Project, the Personal Genome Project, and more than 50 biotech startups,... -
Video/AnimationEngineering Living Materials with Peter Q. NguyenIn this episode of the CoreSpin Podcast Interview Series, host Misha Bagirov sits down with Wyss Senior Scientist Peter Q. Nguyen, Ph.D., to explore how synthetic biology can turn biofilms into useful materials, embed cell-free systems into wearables (like COVID-sensing masks), and program probiotics as future therapeutics. We also talked about the philosophy behind bioengineering,... -
Video/AnimationGeorge Church: Embracing Outliers in Science and in LifeGeorge Church, Ph.D., is a Core Faculty member at the Wyss Institute and a genetics professor at Harvard Medical School. He is a pioneer in synthetic biology and personalized genomics. In 2017, Time magazine named him as one of the 100 most influential people in the world. In addition to being a scientist, Church is...